Higher doses of rifampin appear more effective in fighting TB without increasing risk of adverse events

Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial.

from Top Health News -- ScienceDaily https://ift.tt/2tRTjVD